The 19S proteasomal lid subunit POH1 enhances the transcriptional activation by Mitf in osteoclasts

Journal of Cellular Biochemistry

Volumn 109, Issue 5, 2010, Pages 967-974

  Schwarz, Toni ^a   Sohn, Chee ^a   Kaiser, Bria ^a   Jensen, Eric D ^b   Mansky, Kim C ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Mitf; Osteoclast; POH1; Ubiquitination

Indexed keywords

MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR; OSTEOCLAST DIFFERENTIATION FACTOR; PAD1; PROTEASOME; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; GENE EXPRESSION REGULATION; GENE MUTATION; GENE OVEREXPRESSION; OSTEOCLAST; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEGRADATION; PROTEIN INTERACTION; PROTEIN MOTIF; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; ANIMALS; CELL DIFFERENTIATION; HUMANS; JURKAT CELLS; MACROPHAGES; MICE; MICROPHTHALMIA-ASSOCIATED TRANSCRIPTION FACTOR; MOLECULAR SEQUENCE DATA; NIH 3T3 CELLS; OSTEOCLASTS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN BINDING; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN STRUCTURE, TERTIARY; PROTEIN SUBUNITS; TRANS-ACTIVATORS; TRANSCRIPTIONAL ACTIVATION; TWO-HYBRID SYSTEM TECHNIQUES; UBIQUITINATION;

EID: 77950418771     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22475     Document Type: Article

References (31)

1. Bronisz A, Sharma SM, Hu R, Godlewski J, Tzivion G, Mansky KC, Ostrowski MC. 2006. Microphthalmia-associated transcription factor interactions with 14-3-3 modulate differentiation of committed myeloid precursors. Mol Biol Cell 17:3897-3906.
2. Ciechanover A. 2003. The ubiquitin proteolytic system and pathogenesis of human diseases: A novel platform for mechanism-based drug targeting. Biochem Soc Trans 31:474-481.
3. Glickman MH, Rubin DM, Coux O, Wefes I, Pfeifer G, Cjeka Z, Baumeister W, Fried VA, Finley D. 1998. A subcomplex of the proteasome regulatory particle required for ubiquitin-conjugate degradation and related to the COP9-signalosome and eIF3. Cell 94:615-623.
4. Glickman MH, Rubin DM, Fu H, Larsen CN, Coux O, Wefes I, Pfeifer G, Cjeka Z, Vierstra R, Baumeister W, Fried V, Finley D. 1999. Functional analysis of the proteasome regulatory particle. Mol Biol Rep 26:21-28.
5. Guterman A, Glickman MH. 2004. Deubiquitinating enzymes are IN/(trinsic to proteasome function). Curr Protein Pept Sci 5:201-211.
6. Hemesath TJ, Steingrimsson E, McGill G, Hansen MJ, Vaught J, Hodgkinson CA, Arnheiter H, Copeland NG, Jenkins NA, Fisher DE. 1994. microphthalmia, a critical factor in melanocyte development, defines a discrete transcription factor family. Genes Dev 8:2770-2780.
7. Hideshima T, Richardson P, Chauhan D, Palombella VJ, Elliott PJ, Adams J, Anderson KC. 2001. The proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myeloma cells. Cancer Res 61:3071-3076.
8. Hirst M, Ho C, Sabourin L, Rudnicki M, Penn L, Sadowski I. 2001. A two-hybrid system for transactivator bait proteins. Proc Natl Acad Sci USA 98:8726-8731.
9. Layfield R, Shaw B. 2007. Ubiquitin-mediated signalling and Paget's disease of bone. BMC Biochem 8(Suppl 1): S5.
10. Luchin A, Purdom G, Murphy K, Clark MY, Angel N, Cassady AI, Hume DA, Ostrowski MC. 2000. The microphthalmia transcription factor regulates expression of the tartrate-resistant acid phosphatase gene during terminal differentiation of osteoclasts. J Bone Miner Res 15:451-460.
11. Luchin A, Suchting S, Merson T, Rosol TJ, Hume DA, Cassady AI, Ostrowski MC. 2001. Genetic and physical interactions between Microphthalmia transcription factor and PU.1 are necessary for osteoclast gene expression and differentiation. J Biol Chem 276:36703-36710.
12. Mansky KC, Sankar U, Han J, Ostrowski MC. 2002. Microphthalmia transcription factor is a target of the p38 MAPK pathway in response to receptor activator of NF-kappa B ligand signaling. J Biol Chem 277:11077-11083.
13. Matsumoto M, Kogawa M, Wada S, Takayanagi H, Tsujimoto M, Katayama S, Hisatake K, Nogi Y. 2004. Essential Role of p38 Mitogen-activated Protein Kinase in Cathepsin K Gene Expression during Osteoclastogenesis through Association of NFATc1 and PU.1. J Biol Chem 279:45969-45979.
14. Maytal-Kivity V, Reis N, Hofmann K, Glickman MH. 2002. MPN+, a putative catalytic motif found in a subset of MPN domain proteins from eukaryotes and prokaryotes, is critical for Rpn11 function. BMC Biochem 3:28.
15. McGill GG, Horstmann M, Widlund HR, Du J, Motyckova G, Nishimura EK, Lin YL, Ramaswamy S, Avery W, Ding HF, Jordan SA, Jackson IJ, Korsmeyer SJ, Golub TR, Fisher DE. 2002. Bcl2 regulation by the melanocyte master regulator Mitf modulates lineage survival and melanoma cell viability. Cell 109:707-718.
16. Motyckova G, Weilbaecher KN, Horstmann M, Rieman DJ, Fisher DZ, Fisher DE. 2001. Linking osteopetrosis and pycnodysostosis: Regulation of cathepsin K expression by the microphthalmia transcription factor family. Proc Natl Acad Sci USA 98:5798-5803.
17. Nabhan JF, Ribeiro P. 2006. The 19 S proteasomal subunit POH1 contributes to the regulation of c-Jun ubiquitination, stability, and subcellular localization. J Biol Chem 281:16099-16107.
18. Nabhan JF, Hamdan FF, Ribeiro P. 2002. A Schistosoma mansoni Pad1 homologue stabilizes c-Jun. Mol Biochem Parasitol 121:163-172.
19. Schwartz AL, Ciechanover A. 1999. The ubiquitin-proteasome pathway and pathogenesis of human diseases. Annu Rev Med 50:57-74.
20. Sharma SM, Bronisz A, Hu R, Patel K, Mansky KC, Said S, Ostrowski MC. 2007. Mitf and PU.1 Recruit p38 MAPK and NFATc1 to Target Genes during Osteoclast Differentiation. J Biol Chem 282:15921-15929.
21. So H, Rho J, Jeong D, Park R, Fisher DE, Ostrowski MC, Choi Y, Kim N. 2003. Microphthalmia transcription factor and PU.1 synergistically induce the leukocyte receptor osteoclast-associated receptor gene expression. J Biol Chem 278:24209-24216.
22. Soboleva TA, Baker RT. 2004. Deubiquitinating enzymes: Their functions and substrate specificity. Curr Protein Pept Sci 5:191-200.
23. Spataro V, Toda T, Craig R, Seeger M, Dubiel W, Harris AL, Norbury C. 1997. Resistance to diverse drugs and ultraviolet light conferred by overexpression of a novel human 26 S proteasome subunit. J Biol Chem 272:30470-30475.
24. Stitzel ML, Durso R, Reese JC. 2001. The proteasome regulates the UV-induced activation of the AP-1-like transcription factor Gcn4. Genes Dev 15:128-133.
25. Verma R, Aravind L, Oania R, McDonald WH, Yates JR III, Koonin EV, Deshaies RJ. 2002. Role of Rpn11 metalloprotease in deubiquitination and degradation by the 26S proteasome. Science 298:611-615.
26. Voges D, Zwickl P, Baumeister W. 1999. The 26S proteasome: A molecular machine designed for controlled proteolysis. Annu Rev Biochem 68:1015-1068.
27. Wei N, Tsuge T, Serino G, Dohmae N, Takio K, Matsui M, Deng XW. 1998. The COP9 complex is conserved between plants and mammals and is related to the 26S proteasome regulatory complex. Curr Biol 8:919-922.
28. Weilbaecher KN, Motyckova G, Huber WE, Takemoto CM, Hemesath TJ, Xu Y, Hershey CL, Dowland NR, Wells AG, Fisher DE. 2001. Linkage of M-CSF signaling to Mitf, TFE3, and the osteoclast defect in Mitf(mi/mi) mice. Mol Cell 8:749-758.
29. Wu M, Hemesath TJ, Takemoto CM, Horstmann MA, Wells AG, Price ER, Fisher DZ, Fisher DE. 2000. c-Kit triggers dual phosphorylations, which couple activation and degradation of the essential melanocyte factor Mi. Genes Dev 14:301-312.
30. Xu W, Gong L, Haddad MM, Bischof O, Campisi J, Yeh ET, Medrano EE. 2000. Regulation of microphthalmia-associated transcription factor MITF protein levels by association with the ubiquitin-conjugating enzyme hUBC9. Exp Cell Res 255:135-143.
31. Yao T, Cohen RE. 2002. A cryptic protease couples deubiquitination and degradation by the proteasome. Nature 419:403-407.